I in Injury Board logotype N in Injury Board logotype J in Injury Board logotype U in Injury Board logotype R in Injury Board logotype Y in Injury Board logotype B in Injury Board logotype O in Injury Board logotype A in Injury Board logotype D in Injury Board logotype Search icon Close icon Down arrow icon External link icon Envelope Website link icon Twitter Facebook Instagram icon Linkedin Avvo icon Map marker Phone icon Error icon Checkmark icon
Skip to main content
Steven Davis


About Steven Davis

In his work at TorHoerman Law, Steven Davis fights for the rights of victims harmed by pharmaceutical, medical device, and chemical corporations when they put consumer safety behind their own profit goals.

Steven represents people injured by the wrongful acts of pharmaceutical companies in the development and marketing of dangerous drugs and medical devices. He currently represents individuals suffering serious injuries caused by the use of prescription medications such as Xarelto, Invokana, Zoloft, and fluoroquinolones, and represents hundreds of women injured by defective transvaginal mesh products.  His prior experience includes representing clients injured after use of hormone replacement therapy medications, prescription painkillers, SSRIs, and Pradaxa, including a role as co-liaison counsel for plaintiffs in the Pradaxa MDL, and he has represented many individuals injured by faulty heart devices.

While in law school, Steven worked at the offices of the Saline County, Illinois State’s Attorney and at the offices of the Vanderburgh, Indiana County Prosecutor. He received first-rate courtroom training as a legal representative for the counties, but, believed he could affect more change by pursuing justice for those harmed by companies that put profits ahead of consumer safety.

In the pharmaceutical group at SimmonsCooper, Steven was happy to find others that sought to hold such companies accountable. Since his move to TorHoerman Law in 2009, Steven has continued the fight for the rights of victims harmed by profit-driven decisions made by pharmaceutical corporations.